首页> 外国专利> PEPTIDES DERIVED FROM PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) FOR THE TREATMENT OF HYPERTENSION

PEPTIDES DERIVED FROM PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) FOR THE TREATMENT OF HYPERTENSION

机译：纤溶酶原抑制剂1（PAI-1）衍生的多肽治疗高血压

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to peptides derived from human plasminogen activator inhibitor- 1 (PAI-1) for the treatment of hypertension and complications associated therewith. Particularly, the present invention relates to peptides derived from the amino acid sequence at positions 369-386 of human PAI-1 for the treatment of hypertension.

机译：本发明涉及用于治疗高血压及其相关并发症的源自人纤溶酶原激活物抑制剂-1（PAI-1）的肽。特别地，本发明涉及用于治疗高血压的源自人PAI-1的369-386位氨基酸序列的肽。

著录项

公开/公告号WO2012014214A2

专利类型
公开/公告日2012-02-02

原文格式PDF
申请/专利权人 THROMBOTECH LTD.;LAMENSDORF ITSCHAK;ABD AL-ROOF HIGAZI;NIMROD ABRAHAM;
展开▼

申请/专利号WO2011IL00614
发明设计人 NIMROD ABRAHAM;LAMENSDORF ITSCHAK;ABD AL-ROOF HIGAZI;
展开▼

申请日2011-07-28
分类号A47F7/04;A47B81/00;
国家 WO
入库时间 2022-08-21 17:18:03

相似文献

专利
外文文献
中文文献